3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
2
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
179
Leukemia
162
Lymphoma
116
Lung Neoplasms
107
Carcinoma, Non-Small-Cell Lung
99
Precursor Cell Lymphoblastic Leukemia-Lymphoma
97
Central Nervous System Neoplasms
84
Sarcoma
82
Prostatic Neoplasms
81
Ovarian Neoplasms
76
Colorectal Neoplasms
71
Head and Neck Neoplasms
70
Leukemia, Myeloid, Acute
60
Squamous Cell Carcinoma of Head and Neck
54
Rectal Neoplasms
54
Neuroblastoma
52
Colonic Neoplasms
52
Multiple Myeloma
51
Uterine Cervical Neoplasms
47
Brain Neoplasms
46
Lymphoma, Large B-Cell, Diffuse
45
Leukemia, Lymphocytic, Chronic, B-Cell
41
Carcinoma, Ovarian Epithelial
41
Burkitt Lymphoma
41
Astrocytoma
40
Glioblastoma
39
Fallopian Tube Neoplasms
39
Neoplasm Metastasis
38
Congenital Abnormalities
37
Lymphoma, Follicular
36
Interventions
osimertinib
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
NETWORK
×
Non Small Cell Lung Cancer Metastatic
×
Clear all
NCT03133546
2026-02-06
BOOSTER
ETOP IBCSG Partners Foundation
Phase 2
Completed
155 enrolled
23 charts